APPLICATION
ANDA070043
TYPE
ANDA
ORIGINAL APPROVAL
1985-09-26
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 20MG · TABLET · ORAL
Approval history
1998-12-01Manufacturing (CMC) · Supplement 22AP
1994-12-23Manufacturing (CMC) · Supplement 21AP
1994-10-11Manufacturing (CMC) · Supplement 20AP
1993-08-17Labeling · Supplement 19AP
1992-08-11Labeling · Supplement 18AP
1992-05-01Labeling · Supplement 17AP
1992-04-03Manufacturing (CMC) · Supplement 16AP
1992-04-03Manufacturing (CMC) · Supplement 14AP
1991-04-02Labeling · Supplement 13AP
1988-08-24Manufacturing (CMC) · Supplement 11AP
1987-12-14Manufacturing (CMC) · Supplement 9AP
1986-07-24Manufacturing (CMC) · Supplement 4AP
1986-07-24Manufacturing (CMC) · Supplement 2AP
1986-07-24Manufacturing (CMC) · Supplement 3AP
1986-01-02Manufacturing (CMC) · Supplement 1AP
1985-09-26OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.